These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-002618-40 HIT-REZ 2005 - A multicentre clinical trial and phase II study for the treatment of refractory and relapsed primitive neuroectodermal tumours (medulloblastomas, supratentorial PNETs) and ependymomas i... 2016-01-31 due-trials
Not reported 2005-003557-27 Covered Transjugular Intrahepatic Portosystemic Stent Shunt versus Optimized medical Treatment for the Secondary Prevention of Variceal Bleeding in Cirrhosis 2013-08-29 due-trials
Not reported 2005-006024-11 Prospective, open label, multi center phase II clinical trial of oral BAY 43-9006 (Sorafenib) in patients with relapsed or refractory multiple myeloma 2008-08-01 due-trials
Ongoing 2005-006037-33 Überwachung einer Therapie mit Bromocriptin bei Patienten mit klinisch relevanter Risperidon-induzierter Hyperprolaktinämie. Eine psychiatrisch-endokrinologische Ver-laufsbeobachtung. not-yet-due
Ongoing 2006-001079-39 Interozeptive Aufmerksamkeit, Hitze-Schwelle und körperliche Symptome bei Patienten mit einer depressiven Episode, vor und nach Behandlung mit Duloxetin. Eine Pilotstudie mittels funktioneller Magnet... not-yet-due
Not reported Terminated 2006-004644-24 Prospective, open label, multi center phase II clinical trial with neoadjuvant chemotherapy in addition with Sorafenib in patients with primarily advanced ovarian cancer (FIGO IIIC + IV) and ascites... 2008-06-16 due-trials
Ongoing 2006-006231-49 Ranibizumab in choroidal neovascularization (CNV) due to Pseudoxanthoma elasticum (PXE, Groenblad-Strandberg Syndrome) not-yet-due
Ongoing 2006-006233-40 Ranibizumab in idiopathic macular telangiectasia, type2 A prospective interventional non-randomized study comparing the efficacy and safety of intravitreal ranibizumab (dosing regimen 0.5mg every mon... not-yet-due
Ongoing 2006-006823-38 D-Dimer guided oral anticoagulation therapy for secondary prevention after venous thrombosis not-yet-due
Not reported 2007-003263-52 Gadofosveset Trisodium (Vasovist®) zur kontrastverstärkten MR-Angiographie der supraaortalen Arterien und zur Darstellung der Gefäßwand in der primären Kontrastmittelpassage („first pass“) und in der ... 2010-04-15 due-trials
Not reported 2007-005352-17 A twelve-week, multicenter, randomized, double-blind, placebo-controlled trail of Bupropion for the treatment of apathy in Alzheimer’s Dementia 2014-07-22 due-trials
Completed, but no date 2008-004675-22 Intravitreal ranibizumab in patients with retinal pigment epithelial detachments secondary to AMD bad-data
Not reported 2009-011252-22 Phase III trial of CCNU/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT-methylated glioblastoma patients (CeTeG) 2017-04-06 due-trials
Not reported 2009-015904-24 An open, prospective study to compare the safety and efficacy of raltegravir vs. atazanavir / ritonavir, both in combination with tenofovir DF and emtricitabine, in the treatment of HIV-infection in A... 2012-07-27 due-trials
Completed, but no date 2010-023208-29 Effects of Oxytocin on opioide withdrawal symptoms bad-data
Completed, but no date 2011-005807-33 Intravitreales Ranibizumab zur Therapie von Rissen des retinalen Pigmentepithels bei Pigmentepithelabhebung infolge altersbedingter Makuladegeneration bad-data
Completed, but no date 2012-001419-21 An open label, randomised, non-inferiority trial of pegylated interferon, ribavirin and telaprevir versus pegylated interferon and ribavirin alone in the response guided treatment of acute hepatitis C... bad-data
Other 2013-003492-35 Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation with Dabigatran after Pulmonary Vein Isolation for Atrial Fibrillation not-yet-due
Not reported 2014-003546-27 Chromoendoscopy versus conventional endoscopy in Patients with polyposis syndrome 2017-12-19 due-trials
Completed, but no date 2014-005263-33 Intravitreal Aflibercept (Eylea®) for therapy of choroidal neovascularization and fibrovascular proliferation in patients with Pseudoxanthoma elasticum bad-data
Completed, but no date Terminated 2014-005531-13 Multicenter, open-label single arm phase II study testing the tolerability and the efficacy of Bosutinib step-in dosing in Chronic Phase CML patients intolerant or refractory to previous Imatinib, Nil... bad-data
No trial status on register 2016-001784-36 Multicentre prospective trial for extracranial malignant germ cell tumours including a randomized comparison of Carboplatin and Cisplatin bad-data
Ongoing 2016-004787-20 An Open Label, Randomized Phase 2 Clinical Trial of Nivolumab investigating Effiacy and safety of Nivolumab given once prior to, concurrent to the radiotherapy (RT) and as maintenance therapy over 12 ... not-yet-due
Ongoing 2017-003051-35 Efficacy of BELImumab for therapy-resistant SKIN manifestations in patients with lupus erythematosus (LE): A phase III, multicenter, randomized, double-blind, placebo-controlled, 24-week trial (BELI-S... not-yet-due
Exempt 2017-004130-28 Occurence of Oronasal Fistulas (ONF) using a fibrin sealant patch in primary palatoplasty not-yet-due
Ongoing 2018-004451-20 A multicenter, open label, single-arm pilot study to evaluate the efficacy and safety of guselkumab in patients with moderate to severe palmoplantar pustulosis (PPP) not-yet-due